Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2023-11-08 00:00:00 ET · period of report 2023-11-06 · accession 0001209191-23-054768 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-11-08 | 2023-11-06+ | PHAT | Parikh Asit | Dir | P - Purchase | $7.81 | +7,500 | 52.5K | +17% | +$58.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-06 | P | A | 1,000 | $8.04 | 48,500 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-08 | P | A | 2,500 | $7.80 | 55,000 | D | — | — | |
| 3 | Common | Common Stock | 2023-11-07 | P | A | 4,000 | $7.76 | 52,500 | D | — | — |